Anti-NMDA-Receptor Encephalitis: Case Series and Analysis of the Effects of Antibodies
Lancet Neurol 7:1091-1098, Dalmau,J.,et al, 2008
Toxidrome Recognition in Chemical - Weapons Attacks
NEJM 378:1611-1620, Ciottone, G.R., 2018
Clinical Manifestations of the anti-IgLON5 Disease
Neurol 88:1736-1743,1688, Gaig, C.,et al, 2017
Clinicopathologic Conference, Botulism
NEJM 372:364-372, Case 3-2015, 2015
Heterozygous de-Novo Mutations in ATP1A3 in Patients with Alternating Hemiplegia of Childhood:A Whole-Exome Sequencing Gene-Identification Study
Lancet Neurol 11:764-773, Rosewich,H.,et al, 2012
Multidisciplinary End-of-Life Care for a Patient with Amyotrophic Lateral Sclerosis Requesting Euthanasia
Lancet 402:484, Kruithof,W.J.,et al, 2023
Placebo-Controlled, Randomized, Double-Blind Study of IncobotulinumtoxinA for Sialorrhea
Neurol 92:e1982-e1991, Jost, W.H.,et al, 2019
IgLON5-mediated neurodegeneration is a differential diagnosis of CNS Whipple disease
Neurol 90:1113-1115, Morales-Briceno, H.,et al, 2018
Non-Alzheimers Dementia 2 Lewy Body Dementias
Lancet 386:1683-1697, Walker, Z.,et al, 2015
Viral Infections of the Nervous System, Chronic Meningitis, and Prior Diseases, Rabies
Adams & Victors Principles of Neurology, Chp 33, pg 753, Ropper, A.H.,et al, 2014
Managing Acute Organophosphorus Pesticide Poisoning
BMJ 334:629-634, Roberts,D.M.&Aaron,C.K., 2007
Injections of Botulinum Toxin A Into the Salivary Glands Improve Sialorrhoea in Amyotrophic Lateral Sclerosis
JNNP 69:121-123, Giess,R. et al, 2000
Practice Parameter:The Care of the Patient with Amyotrophic Lateral Sclerosis (An Evidence-Based Review), Report of the Quality Standards Subcommittee of the AAN
Neurol 52:1311-1323, Miller,R.G.,et al, 1999
Envenomation by the Scorpion Centruroides Exilicauda (C Sculpturatus) :Severe and Unusual Manifestations
Pediatrics 87:930-933, Berg,R.A.&Tarantino,M.D., 1991
Numbness of Half of the Tongue
Can J Neurol Sci 13:107-108, Sadler, R.M.,et al, 1986